Company Filing History:
6 out of 11 
6 out of 101 Years Active: 2006-2011
Title: Leah Klapper: Innovator in Immunomodulatory Therapies
Introduction
Leah Klapper is a prominent inventor based in Givataim, Israel, known for her significant contributions to the field of immunology. With a total of six patents to her name, she has made remarkable strides in developing therapies aimed at treating immunodeficiency and cancer.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency." This invention provides a humanized monoclonal antibody that exhibits immunostimulatory effects. The antibody specifically binds to B lymphoblastoid cells, inducing proliferation and activation of peripheral blood lymphocytes, particularly T cells. It is capable of eliciting an anti-tumor effect upon administration to subjects suffering from immune deficiency. Another notable patent is "Peptide useful in immunomodulation," which presents peptides and polynucleotides for immunomodulation, immunotherapy, and vaccine development, particularly for anti-cancer therapy and diagnostic purposes. The immunomodulatory effect includes the induction of proliferation and activation of peripheral blood lymphocytes, leading to an anti-tumor effect in cancer patients.
Career Highlights
Leah has worked with several companies, including Curetech Ltd. and Mor Research Applications Ltd., where she has applied her expertise in immunology to develop innovative therapies. Her work has been instrumental in advancing the understanding and treatment of immune-related conditions.
Collaborations
Leah has collaborated with notable professionals in her field, including Britta Hardy and Steven Tarran Jones. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Leah Klapper's innovative work in immunomodulatory therapies showcases her dedication to improving health outcomes for individuals with immunodeficiency and cancer. Her patents reflect her commitment to advancing medical science and her impact on the field of immunology.